tirzepatide or retatrutide vs (Research Comparison) Peptides for Weight Loss Research:

Indias drug regulator, the CDSCO, has stated that GLP-1 obesity drugs are approved with the condition that they be prescribed only by qualified specialists after proper evaluation, per PIB, Government of India, 2025-26

Some patients experience rapid weight regain when stopping GLP-1s, which could affect surgical planning if significant weight change occurs

It's intended for long-term use in diabetes management

Individual experiences tell the rest

According to the Indiana University School of Medicine, prior research suggests that, in the United States alone, the use of GLP-1s have increased by fortyfold between 2017 and 2021

Prevention of diet-induced obesity: healthy, nonobese animals at baseline receiving experimental treatment while receiving a high-fat diet